X
Xeris Biopharma Holdings D
D
XERS
4.36000
USD
-0.06
(-1.25%)
مغلق
حجم التداول
46,586
الربح لكل سهم
-0
العائد الربحي
-
P/E
-15
حجم السوق
698,275,800
الأخبار المقالات
العنوان: Xeris Biopharma Holdings
القطاع: Healthcare
الصناعة: Biotechnology
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).